SCHEMBL29135823

SCHEMBL29135823

O=C(NC(F)C(F)F)c1ccc(Br)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 1/20 0.58
MMP2 P08253 1/20 0.58
CA14 Q9ULX7 1/20 0.58
OGG1 O15527 1/20 0.52
ALDH1A1 P00352 3/20 0.51
LMNA P02545 2/20 0.51
SMN1; SMN2 Q16637 4/20 0.47
KMT2A Q03164 5/20 0.45
HSP90AA1 P07900 2/20 0.45
CES2 O00748 1/20 0.45
CES1 P23141 1/20 0.45
GAA P10253 2/20 0.43
KDM4E B2RXH2 1/20 0.43
MAPT P10636 1/20 0.43
GFER P55789 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
HPGD P15428 1/20 0.43
TRPA1 O75762 1/20 0.43
MEN1 O00255 3/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28983041 0.80 CTRB1 (0.53) CA12ALDH1A1LMNASMN1; SMN2GAA
SCHEMBL28941491 0.76 CHRNA1 (0.48) SMN1; SMN2HPGDHDAC1CA1CA2
SCHEMBL13062204 0.76 ALDH1A1 (0.64) CA12MMP2CA14OGG1ALDH1A1
SCHEMBL1923460 0.74 CA12 (0.54) CA12MMP2CA14OGG1ALDH1A1
SCHEMBL970081 0.73 MMP2 (0.58) CA12MMP2CA14OGG1ALDH1A1
SCHEMBL6559629 0.73 CA12 (0.53) CA12MMP2CA14OGG1ALDH1A1
SCHEMBL13481186 0.72 POLB (0.68) OGG1ALDH1A1LMNASMN1; SMN2KMT2A
SCHEMBL8575405 0.72 OGG1 (0.67) CA12MMP2CA14OGG1ALDH1A1
SCHEMBL1982518 0.72 POLB (0.68) OGG1ALDH1A1LMNASMN1; SMN2KMT2A
SCHEMBL11068295 0.72 OGG1 (0.67) CA12MMP2CA14OGG1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111655681-B Heterocyclylamino-substituted triazoles as modulators of Rho-related protein kinases 莱德克斯制药公共有限公司 2024-01-05 CN disclosed